United Kingdom Endocrine Testing Market Insight
The United Kingdom Endocrine Testing Market is growing at an 8.2%CAGR, driven by rising hormonal disorder prevalence, increasing diagnostic awareness, technological advancements, and expanding laboratory infrastructure.
United Kingdom Endocrine Testing Market Insights Forecasts to 2035
- The United Kingdom Endocrine Testing Market Size Was Estimated at USD 510.2Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.2% from 2025 to 2035
- The United Kingdom Endocrine Testing Market Size is Expected to Reach USD 1121.7Million by 2035
Notable Insightsfor United Kingdom Endocrine Testing Market
- By test type, thyroid function testing dominated, accounting for approximately 35–40% share in 2024, driven by high incidence of thyroid disorders.
- Bytechnology, immunoassays held approximately 50–55% share, due to accuracy, automation, and widespread adoption in diagnostic labs.
- Approximately 40–45% of diagnostic testing is outsourced to specialized laboratories, reflecting demand for advanced testing capabilities.
- Around 55–65% of healthcare providers prefer centralized labs for endocrine testing to ensure quality, efficiency, and regulatory compliance.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Endocrine Testing Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Endocrine Testing Market
- Thermo Fisher Scientific
- Siemens Healthineers
- Abbott Laboratories
- Roche Diagnostics
- Bio-Rad Laboratories
- Quest Diagnostics
- Randox Laboratories
- SYNLAB
- Others
Recent Developments:
- In January 2026, Cancer and Metabolic Clinical Trials: The Trans-EndoNET launched in UK to assess insulin resistance impact on aromatase inhibitor response in breast cancer, funded by UKRI MRC and NIHR.
- In July 2023, Endocrine Genetic Testing Training: NHS Genomics Education Programme launched GeNotes endocrinology collection to enhance genomic knowledge for diagnosing hereditary endocrine disorders across UK endocrine testing pathways.
Market Segmentation:
United Kingdom Endocrine Testing Market, By Test Type
- Thyroid Testing
- Insulin Testing
- Cortisol Testing
- Reproductive Hormone Testing
- Others
United Kingdom Endocrine Testing Market, By Technology
- Immunoassay
- Tandem Mass Spectrometry
- Chromatography
- Others
United KingdomEndocrine Testing Market, By End User
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
United Kingdom Endocrine Testing Market, By Phase
- Routine Testing
- Specialized Testing
Expert Views:
The UK Endocrine Testing Market is expected to experience consistent growth due to the rising prevalence of diabetes, thyroid disorders, and hormonal imbalances. Experts emphasize that advancements in diagnostic technologies, including high-sensitivity assays and mass spectrometry, will improve accuracy and early detection. Increasing demand for personalized medicine and preventive healthcare is also driving testing volumes. Additionally, integration of digital health tools and laboratory automation is expected to enhance efficiency, reduce turnaround time, and support long-term market expansion through 2035.